Synbiotics, probiotics, prebiotics, and postbiotics

The International Scientific Association for Probiotics and Prebiotics (ISAPP) has published landmark consensus frameworks defining the boundaries of each category to prevent deceptive consumer marketing. ISAPP consensus statement on probiotics (PMID 24912386) ISAPP consensus statement on prebiotics (PMID 28611480)

Probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. To qualify, organisms must be identified down to the strain level, proven safe, and backed by human clinical trials confirming viability through the gastrointestinal tract. ISAPP consensus statement on probiotics (PMID 24912386) NCCIH probiotics: what you need to know

Prebiotics are substrates selectively utilized by host microorganisms that confer a health benefit. Common examples include inulin, fructooligosaccharides (FOS), and galactooligosaccharides (GOS). Unlike general dietary fiber that merely adds bulk, prebiotics selectively stimulate beneficial indigenous taxa like Bifidobacterium. ISAPP consensus statement on prebiotics (PMID 28611480) FDA questions and answers on dietary fiber

Synbiotics combine live microbes with prebiotic substrates. ISAPP recognizes two distinct classes: synergistic synbiotics, where the prebiotic substrate is specifically chosen to feed the co-administered live strain, and complementary synbiotics, where each component independently targets the microbiome. ISAPP consensus statement on synbiotics

Postbiotics represent preparations of inanimate microorganisms and their components that confer a health benefit. They contain dead cell walls, lipoteichoic acids, and cellular metabolites that interact with gut immune receptors without requiring live cell survival. Pure isolated chemicals, like synthetic butyrate salts, do not meet this definition. ISAPP consensus statement on postbiotics

Probiotic taxonomy follows a strict hierarchy: genus (such as Bifidobacterium), species (animalis), subspecies (lactis), and strain designation (such as BB-12 or HN019). Two different strains within the same species can exhibit entirely distinct enzymatic activities, immune signaling properties, and clinical effects. NCCIH probiotics: what you need to know NIH ODS probiotics fact sheet

When a supplement label lists only Lactobacillus plantarum without a strain designation, consumers cannot verify whether the product contains a clinically tested strain or an uncharacterized generic culture. Premium brands explicitly print the strain designation alongside the specific CFU count allocated to that strain. FDA dietary supplement labeling guide ISAPP consensus statement on probiotics (PMID 24912386)

Proprietary probiotic blends represent a major industry loophole. Manufacturers lump 10 different strains together under a single total milligram or CFU number, allowing them to fill the capsule with cheap strains while fairy-dusting expensive therapeutic strains at sub-clinical levels. FDA dietary supplement labeling guide FTC health products compliance guidance

Live bacteria are highly vulnerable to heat, oxygen, and ambient humidity. When a label states viable cells at time of manufacture, it reveals nothing about how many living bacteria survive when consumed months later. Microbial mortality in un-refrigerated, non-desiccant bottles can exceed 80 percent. NIH ODS probiotics fact sheet FDA dietary supplement labeling guide

Reputable manufacturers formulate with calculated manufacturing overages (often 20 to 50 percent) and guarantee live CFU counts through the stated expiration date. They also utilize specialized CSP desiccant-lined bottles or moisture-barrier blister packs to protect sensitive cultures. NIH ODS probiotics fact sheet FDA dietary supplement labeling guide

Clinical trials establishing bifidogenic effects from prebiotics like inulin and FOS typically utilize daily doses between 3 and 10 grams. At these levels, prebiotic fibers selectively nourish beneficial saccharolytic bacteria in the colon, producing beneficial short-chain fatty acids. ISAPP consensus statement on prebiotics (PMID 28611480) FDA questions and answers on dietary fiber

Many multi-ingredient capsules claim prebiotic support while providing only 50 to 200 milligrams of prebiotic powder. This amount is physiologically meaningless for altering microbial community structure, representing label ornamentation rather than functional nutrition. FDA questions and answers on dietary fiber FTC health products compliance guidance

Conversely, introducing sudden large doses of prebiotic fiber can cause acute osmotic gastrointestinal distress, including painful gas, severe abdominal cramps, and diarrhea, particularly in individuals with small intestinal bacterial overgrowth (SIBO) or irritable bowel syndrome (IBS). FDA questions and answers on dietary fiber NCCIH probiotics: what you need to know

While probiotics exhibit strong safety records in healthy populations, they are living biological agents that require caution in clinical settings. The National Institutes of Health Office of Dietary Supplements warns that rare instances of bacteremia and fungemia have occurred following probiotic use in high-risk patients. NIH ODS probiotics fact sheet

Individuals with severe acute pancreatitis, central venous catheters, extensive intestinal mucosal barrier damage, or profound immunocompromise should only initiate probiotic therapy under direct physician supervision. In these vulnerable cohorts, postbiotics provide a potentially safer alternative because they contain zero live replicating microbes. NIH ODS probiotics fact sheet ISAPP consensus statement on postbiotics

For research and educational purposes only. Not medical advice. FDA dietary supplement labeling guide

• Mood and gut claim guide
• GLP-1 satiety guide
• Transparency checklist